NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer
June 30, 2022
NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer Read More »
June 2022
The Column Group Raises $1.23 Billion in Two New Funds
We are very excited to announce that we have closed the two newest funds of the TCG fund family – The Column Group V (“TCG V”), a $615 million fund focused on early-stage investments, and The Column Group Opportunity III (“TCG Opportunity III”), also $615 million but focused on later stage investments in our companies.
The Column Group Raises $1.23 Billion in Two New Funds Read More »
